Crocs, Inc.
CROX
$122.24
-0.62%
Crocs, Inc. designs, develops, markets, and distributes casual lifestyle footwear and accessories for men, women, and children, operating through two reportable segments: the core Crocs Brand and the acquired HEYDUDE Brand. The company is a global leader in the casual footwear space, distinguished by its proprietary Croslite material and iconic clog silhouette, which have cultivated a loyal and expanding consumer base. The current investor narrative is dominated by the turnaround efforts for the HEYDUDE brand, which has struggled since its acquisition, alongside the resilience of the core Crocs brand. Recent analyst upgrades and better-than-expected earnings have fueled optimism, but the stock remains volatile as the market debates whether the HEYDUDE overhang can be resolved and whether the core brand's growth can be sustained amid a challenging consumer discretionary environment.…
CROX
Crocs, Inc.
$122.24
Related headlines
Investment Opinion: Should I buy CROX Today?
Based on the synthesis of valuation, growth, and risk factors, the recommendation is a Hold with a bias toward accumulation on weakness. The core thesis is that Crocs is deeply undervalued on a forward PE of 7.53x and offers a 22.9% upside to the analyst average target of $138.25, but the HEYDUDE overhang and recent negative momentum warrant caution until there are clearer signs of a turnaround. The consensus rating is 'Buy' (mean 2.33), but the wide target range ($95-$163) and a sell rating from Goldman Sachs highlight the lack of unanimity.
Supporting evidence includes the attractive valuation: forward PE of 7.53x versus historical range of 8x-15x, PS ratio of 1.15 versus industry average of 1.5-2.0, and PEG ratio of 0.52. Revenue growth is negative at -1.69% YoY, but the core Crocs Brand remains resilient with $767.42 million in quarterly revenue and a 56.75% gross margin. Profitability is solid with a 14.93% net margin and $670.66 million in TTM free cash flow, which supports share buybacks and debt reduction. The implied upside to the average target is 22.9%, and the stock trades at a discount to peers on most metrics.
The biggest risks that could invalidate the thesis are: 1) a failure to stabilize HEYDUDE, leading to further impairments and revenue declines; 2) a consumer discretionary slowdown that pressures the core brand; and 3) high debt levels (D/E of 1.25) limiting financial flexibility. The rating would upgrade to Buy if HEYDUDE shows sequential revenue growth and gross margins stabilize above 57%, or if the stock drops below $100 (forward PE below 6.7x). It would downgrade to Sell if revenue declines accelerate beyond -5% YoY or if free cash flow turns negative. Relative to its history and peers, CROX appears undervalued, but the discount is justified by execution risks.
Sign up to view all
CROX 12-Month Price Forecast
The 12-month outlook for CROX is balanced, with a neutral stance due to the tug-of-war between deep value and execution risks. The forward PE of 7.53x and strong free cash flow suggest the stock is undervalued, but the HEYDUDE overhang and negative momentum could keep a lid on gains until there is tangible progress. The base case (55% probability) targets $125-$138, assuming stabilization but not a full turnaround. I would upgrade to bullish if HEYDUDE shows sequential revenue growth and gross margins expand above 58%, or downgrade to bearish if revenue declines accelerate beyond -5% YoY or free cash flow deteriorates.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crocs, Inc.'s 12-month outlook, with a consensus price target around $138.25 and implied upside of +13.1% versus the current price.
Average Target
$138.25
0 analysts
Implied Upside
+13.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$95 - $163
Analyst target range
The stock is covered by 12 analysts, with a consensus recommendation of "Buy" (recommendation mean of 2.33, where 1 is Strong Buy and 5 is Strong Sell). The average target price is $138.25, implying an upside of 22.9% from the current price of $112.48. The consensus leans bullish, with recent upgrades from Piper Sandler (Overweight), Baird (Outperform), and Seaport Global (Buy), indicating growing optimism. However, there are also hold ratings from Stifel, UBS, and Barclays, and a sell rating from Goldman Sachs, reflecting some caution. The bullish sentiment is driven by the core brand's resilience and the potential for HEYDUDE to stabilize, while bears point to competitive pressures and macroeconomic headwinds.
The target price range is wide, from a low of $95.00 to a high of $163.00, representing a spread of 71.6% relative to the current price. The high target of $163.00 assumes a successful HEYDUDE turnaround, margin expansion, and multiple re-rating, while the low target of $95.00 prices in continued weakness in HEYDUDE, margin compression, and a challenging consumer environment. The wide spread indicates high uncertainty and divergent views among analysts. The recent upgrades suggest that sentiment is shifting positively, but the presence of a sell rating from Goldman Sachs highlights the risks. Overall, the analyst community sees significant upside potential, but the wide range underscores the need for careful risk assessment.
Drowning in data?
Find the real signal!
Bulls vs Bears: CROX Investment Factors
The bull case for CROX rests on its deep value valuation (forward PE of 7.53x), strong free cash flow ($670.66 million TTM), and significant analyst upside (22.9% to average target). The bear case centers on the HEYDUDE brand's persistent weakness, which caused a 1.69% YoY revenue decline and a massive impairment, along with high debt (D/E of 1.25) and negative ROE. Currently, the bear evidence appears slightly stronger due to the recent price weakness (-13.88% in 1 month) and operational challenges, but the valuation discount and cash flow generation provide a compelling counterbalance. The single most important tension is whether HEYDUDE can be stabilized or divested without further damaging profitability; resolution of this overhang could unlock significant upside, while continued deterioration could justify the low multiple.
Bullish
- Deep Value Forward PE: CROX trades at a forward PE of just 7.53x based on estimated EPS of $14.83, which is near the low end of its 5-year historical range of 8x-15x. This multiple is less than half the broader market and well below the apparel/footwear industry average, suggesting the market is pricing in excessive pessimism.
- Strong Free Cash Flow Generation: The company generated $670.66 million in trailing twelve-month free cash flow, representing a robust 14.5% FCF yield on its $4.64 billion market cap. This cash generation supports continued share repurchases ($245.5 million in Q1 2026 alone) and debt reduction ($74.76 million), enhancing per-share value.
- Analyst Consensus Upside: With 12 analysts covering the stock, the consensus recommendation is 'Buy' (mean 2.33) and the average target price of $138.25 implies 22.9% upside from the current $112.48. Recent upgrades from Piper Sandler, Baird, and Seaport Global signal improving sentiment.
- Core Brand Resilience: The core Crocs Brand generated $767.42 million in Q1 2026 revenue, representing 83.3% of total revenue, and continues to be a stable profit engine. Despite a 1.69% YoY revenue decline, the core brand's gross margin remains healthy at 56.75%, and its iconic product line sustains a loyal customer base.
Bearish
- HEYDUDE Impairment and Revenue Drag: The HEYDUDE brand contributed only $154.04 million in Q1 2026 revenue and was the primary cause of the 1.69% YoY total revenue decline. The Q2 2025 non-cash impairment charge of $759.2 million resulted in a trailing twelve-month net loss, highlighting the significant overhang from this acquisition.
- High Debt and Negative ROE: The debt-to-equity ratio of 1.25 is relatively high, and the trailing ROE is -6.28% due to the impairment. While ROA is positive at 11.99%, the negative ROE reflects the balance sheet strain and raises concerns about capital allocation.
- Recent Price Weakness and Underperformance: The stock is down 13.88% over the past month and 9.81% over the past three months, significantly underperforming the S&P 500 by 12.82% and 12.85% respectively. This negative momentum could signal further downside if support at $108.83 fails.
- High Volatility and Short Interest: With a beta of 1.514, CROX is 51.4% more volatile than the market, and a short ratio of 4.73 indicates active short selling. Any negative news could trigger a sharp sell-off, as evidenced by the 24.25% maximum drawdown over the past year.
CROX Technical Analysis
CROX is in a medium-term recovery after a volatile 12-month period, with the stock up 38.95% over the past year. The current price of $112.48 sits at approximately 57.6% of its 52-week range, calculated as ($112.48 - $73.21) / ($141.28 - $73.21). This positioning suggests the stock is neither overextended nor deeply undervalued, but rather in a neutral zone that reflects the market's balanced view of the company's prospects. The 52-week high of $141.28 was reached in early August 2026, while the low of $73.21 occurred in March 2026, indicating a significant recovery from the lows but also a notable pullback from the highs.
Short-term momentum has turned negative, with the stock down 13.88% over the past month and 9.81% over the past three months, diverging from the positive 1-year and 6-month gains of 38.95% and 44.30%, respectively. This divergence suggests a potential trend reversal or a healthy correction after a strong run. The relative strength versus the S&P 500 over the past month is -12.82%, indicating significant underperformance, while the 1-year relative strength is +22.73%, highlighting the stock's longer-term outperformance. The recent pullback may be attributed to profit-taking or concerns about the HEYDUDE brand, but the longer-term uptrend remains intact as long as key support levels hold.
Key technical levels to watch include support at the 52-week low of $73.21 and resistance at the 52-week high of $141.28. A breakdown below the recent low of $108.83 (September 10, 2026) could signal further weakness, while a breakout above $141.28 would confirm a resumption of the uptrend. The stock's beta of 1.514 indicates it is 51.4% more volatile than the broader market, which means investors should be prepared for larger price swings. This elevated volatility, combined with a short ratio of 4.73, suggests that short sellers are active, and any positive catalyst could trigger a short squeeze, amplifying upward moves.
Beta
1.51
1.51x market volatility
Max Drawdown
-24.3%
Largest decline past year
52-Week Range
$73-$141
Price range past year
Annual Return
+52.1%
Cumulative gain past year
| Period | CROX Return | S&P 500 |
|---|---|---|
| 1m | -2.8% | -1.0% |
| 3m | -2.2% | +2.0% |
| 6m | +61.3% | +17.4% |
| 1y | +52.1% | +15.0% |
| ytd | +40.6% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CROX Fundamental Analysis
Crocs' revenue trajectory has been mixed, with the most recent quarter (Q1 2026) showing revenue of $921.46 million, a decline of 1.69% year-over-year. This follows a Q4 2025 revenue of $957.64 million and Q3 2025 revenue of $996.30 million, indicating a sequential decline. The core Crocs Brand segment generated $767.42 million in revenue, while the HEYDUDE Brand contributed $154.04 million. The year-over-year decline is primarily due to weakness in the HEYDUDE brand, which has been a drag on overall growth. The company's ability to return to growth will depend on stabilizing HEYDUDE and sustaining the core brand's momentum.
Profitability remains solid, with a net income of $137.56 million in Q1 2026 and a net margin of 14.93%. The gross margin was 56.75%, down from 57.78% in Q1 2025, but still healthy for the footwear industry. Operating margin was 21.80%, and EBITDA margin was 23.83%. The company has been consistently profitable, with net income ranging from $105.17 million to $145.82 million over the past four quarters, except for a significant loss in Q2 2025 due to a non-cash impairment charge related to HEYDUDE. Excluding that charge, the underlying profitability remains robust, and margins are expected to stabilize as HEYDUDE restructuring efforts progress.
The balance sheet shows a debt-to-equity ratio of 1.25, which is relatively high but manageable given the company's strong cash flow generation. Free cash flow for the trailing twelve months was $670.66 million, and the current ratio is 1.27, indicating adequate liquidity. However, the company has been using cash flow to repurchase shares and repay debt, with $245.50 million in stock repurchases in Q1 2026 and $74.76 million in debt repayment. The return on equity (ROE) is -6.28% on a trailing basis due to the Q2 2025 impairment, but the return on assets (ROA) is 11.99%, reflecting the underlying profitability of the business. Overall, the financial health is stable, but the high debt level warrants monitoring.
Quarterly Revenue
$921457000.0B
2026-03
Revenue YoY Growth
-1.7%
YoY Comparison
Gross Margin
56.8%
Latest Quarter
Free Cash Flow
$670662000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CROX Overvalued?
Since Crocs reported positive net income in the most recent quarter (Q1 2026) but a trailing twelve-month net loss due to the Q2 2025 impairment, the trailing PE ratio is negative (-57.01) and not meaningful. Therefore, the forward PE ratio is the most appropriate metric, which stands at 7.53x based on estimated EPS of $14.83. This low forward multiple suggests the market is pricing in significant uncertainty, likely related to the HEYDUDE brand and broader consumer discretionary headwinds. The gap between the trailing and forward PE is not applicable due to the negative trailing earnings, but the forward PE alone indicates that investors are expecting a recovery in earnings.
Compared to the industry average, Crocs trades at a discount. The price-to-sales (PS) ratio is 1.15, while the industry average PS for apparel/footwear is typically around 1.5-2.0. The price-to-book (PB) ratio is 3.58, which is also below the industry average of 4.0-5.0. The EV/EBITDA ratio is 25.44, which is relatively high compared to the industry average of 15-20, but this is inflated by the impairment charge. On a forward basis, the EV/EBITDA is likely much lower. The PEG ratio of 0.52 suggests the stock is undervalued relative to its expected growth, but the growth estimates may be conservative. Overall, Crocs appears undervalued compared to peers, but the discount may be justified by the HEYDUDE overhang and execution risks.
Historically, Crocs' valuation has been volatile. The current forward PE of 7.53x is near the low end of its historical range, which has typically been between 8x and 15x over the past five years. The PS ratio of 1.15 is also near multi-year lows, compared to historical levels above 2.0. This suggests that the market is pricing in pessimistic expectations, potentially creating a value opportunity if the company can successfully turn around HEYDUDE and return to growth. However, the low valuation could also reflect structural challenges, such as slowing demand for casual footwear or increased competition.
PE
-57.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 4x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks for Crocs are primarily tied to its high debt burden and the HEYDUDE acquisition overhang. The debt-to-equity ratio of 1.25 is elevated for the footwear industry, and the company has negative trailing ROE of -6.28% due to the Q2 2025 impairment charge. Revenue declined 1.69% year-over-year in Q1 2026, driven by HEYDUDE's weakness, and gross margin compressed to 56.75% from 57.78% a year earlier. While free cash flow remains robust at $670.66 million TTM, the company is using a significant portion for share repurchases ($245.5 million in Q1 2026) and debt repayment, which may limit flexibility if earnings deteriorate further.
Market and competitive risks include the stock's high beta of 1.514, making it 51.4% more volatile than the broader market, and a short ratio of 4.73 that indicates active short selling. The forward PE of 7.53x is near historical lows, but this discount could persist if HEYDUDE fails to turn around or if consumer discretionary spending weakens. Recent news highlights analyst optimism about brand recovery, but also underscores the HEYDUDE overhang. Competition in casual footwear is intense, and Crocs' reliance on the core clog silhouette exposes it to shifting fashion trends. Additionally, the wide analyst target range ($95-$163) reflects divergent views on execution risk.
The worst-case scenario involves a continued decline in HEYDUDE sales, further margin erosion, and a broader consumer slowdown, leading to a breakdown below the 52-week low of $73.21. From the current price of $112.48, that represents a downside of approximately 34.9%. If the company fails to stabilize HEYDUDE and core brand growth stalls, the stock could retest the March 2026 low, especially if debt covenants tighten or if a recession reduces discretionary spending. The maximum drawdown over the past year was 24.25%, but a more severe scenario could see losses exceeding 35% as the market reprices the stock to a distressed valuation.
FAQ
The key risks for CROX are ranked as follows: 1) HEYDUDE execution risk – the brand contributed only $154.04 million in Q1 2026 revenue and caused a $759.2 million impairment, and further declines could lead to additional write-downs. 2) Financial risk – the debt-to-equity ratio of 1.25 is high, and negative ROE of -6.28% indicates balance sheet strain. 3) Market risk – with a beta of 1.514, the stock is 51.4% more volatile than the market, and a short ratio of 4.73 means short sellers could amplify downside. 4) Macro risk – as a consumer discretionary stock, Crocs is sensitive to inflation and reduced spending, which could pressure the core brand. Each risk is significant, but HEYDUDE is the most immediate threat.
The 12-month forecast for CROX is based on three scenarios. The bull case (25% probability) targets $141.28-$163.00, assuming HEYDUDE stabilizes and margins expand. The base case (55% probability) targets $125.00-$138.25, assuming stabilization but not a full turnaround, with revenue roughly flat. The bear case (20% probability) targets $73.21-$95.00, assuming continued HEYDUDE declines and a consumer slowdown. The most likely scenario is the base case, which implies a return to the analyst average target of $138.25, representing 22.9% upside. The key assumption is that HEYDUDE revenue declines moderate and gross margins hold above 56.5%.
CROX appears undervalued on most metrics. Its forward PE of 7.53x is near the low end of its 5-year range of 8x-15x, and its PS ratio of 1.15 is below the industry average of 1.5-2.0. The PEG ratio of 0.52 suggests the stock is cheap relative to expected growth. However, the trailing PE is negative (-57.01) due to the Q2 2025 impairment, and the EV/EBITDA of 25.44 is inflated by the same charge. The market is pricing in significant uncertainty around HEYDUDE, which may justify the discount. If the company can resolve the HEYDUDE issues, the multiple could expand toward historical averages, implying fair value closer to $138.
From a risk/reward perspective, CROX offers a compelling but risky opportunity. The stock trades at a forward PE of 7.53x, with a 22.9% upside to the analyst average target of $138.25, and generates $670.66 million in free cash flow. However, the HEYDUDE brand remains a significant overhang, having caused a 1.69% YoY revenue decline and a massive impairment. The high debt-to-equity ratio of 1.25 and negative ROE of -6.28% add financial risk. For investors with a high risk tolerance and a long-term horizon, the valuation discount may be attractive, but it is not a slam dunk. It is a good buy only if you believe HEYDUDE can be stabilized and are comfortable with volatility (beta 1.514).
CROX is more suitable for long-term investment (minimum 2-3 years) given its turnaround nature and high volatility. The stock does not pay a dividend (payout ratio 0), so returns depend entirely on capital appreciation. Its beta of 1.514 and recent 24.25% max drawdown make it risky for short-term trading, though the high short ratio (4.73) could create short-squeeze opportunities for traders. For long-term investors, the deep value (forward PE 7.53x) and strong free cash flow ($670.66 million) provide a margin of safety, but patience is required as the HEYDUDE turnaround unfolds. A minimum holding period of 2-3 years allows time for the brand to stabilize and for the valuation to normalize.
